Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Louis G. Lange currently holds 54,979 shares of Audentes Therapeutics, Inc. (BOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis G. Lange has been a net seller of BOLD stock. They have purchased $294.0K and sold $19.7M worth of shares.
Louis G. Lange's most recent insider trade was on Mar 9, 2026, when they sold 44,619 shares at $0.00 per share.
Louis G. Lange serves as Executive at Audentes Therapeutics, Inc. (BOLD). They have executed 170 insider transactions totaling $20.0M over their tenure at the company.
Louis G. Lange holds the position of Executive at Audentes Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Louis G. Lange has shown a selling trading pattern, with $294.0K in total purchases and $19.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Louis G. Lange was on Jan 15, 2020, when they sold $15.9M worth of BOLD shares. This transaction involved 265,799 shares at $60.00 per share.
Louis G. Lange currently owns 54,979 shares of Audentes Therapeutics, Inc. (BOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Louis G. Lange's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Louis G. Lange has 170 Form 4 filings on record as an insider at Audentes Therapeutics, Inc..
Set alerts for Louis G. Lange and 40,000+ other insiders.